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http://www.biomedcentral.com/1471-2458/14/288RESEARCH ARTICLE Open AccessEquity in human papilloma virus vaccination
uptake?: sexual behaviour, knowledge and
demographics in a cross-sectional study in
(un)vaccinated girls in the Netherlands
Madelief Mollers1,2†, Karin Lubbers3†, Symen K Spoelstra3, Willibrord CM Weijmar-Schultz3, Toos Daemen4,
Tjalke A Westra4, Marianne AB van der Sande1,5, Hans W Nijman3, Hester E de Melker1 and Adriana Tami4,6*Abstract
Background: In the Netherlands, human papillomavirus (HPV) vaccination is part of a national program equally
accessible for all girls invited for vaccination. To assess possible inequalities in vaccine uptake, we investigated
differences between vaccinated and unvaccinated girls with regard to various characteristics, including education
and ethnicity, (both associated with non-attendance to the national cervical screening program), sexual behaviour
and knowledge of HPV.
Methods: In 2010, 19,939 nationwide randomly-selected 16–17 year-old girls (2009 vaccination campaign) were
invited to fill out an online questionnaire. A knowledge scale score and multivariable analyses identified variables
associated with vaccination status.
Results: 2989 (15%) of the selected girls participated (65% vaccinated, 35% unvaccinated). The participants were
comparable with regard to education, ethnicity, most sexual risk behaviour and had similar knowledge scores on HPV
transmission and vaccination. However, unvaccinated girls lived in more urbanised areas and were more likely to have a
religious background. Irrespective of vaccination status, 81% of the girls were aware of the causal relationship between
HPV and cervical cancer, but the awareness of the necessity of cervical screening despite being vaccinated was limited.
Conclusions: HPV vaccine uptake was not associated with knowledge of HPV and with factors that are known to be
associated with non-attendance to the cervical cancer screening program in the Netherlands. Furthermore, most sexual
behaviour was not related to vaccination status meaning that teenage unvaccinated girls were not at a disproportionally
higher risk of being exposed to HPV. Routine HPV vaccination may reduce the social inequity of prevention of cervical cancer.
Keywords: Monitoring, Human papilloma virus, Vaccination uptake, Sexual behaviour, KnowledgeBackground
Human papillomavirus (HPV) infection is one of the most
common sexually transmitted infections (STI) worldwide.
By the age of 50, about 80% of sexually active women
will acquire HPV [1-3]. Most infections are transient* Correspondence: a.tami@umcg.nl
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reproduction in any medium, provided the orand around 90% clears within two years [4,5]. However,
a persisting high-risk HPV infection is the most im-
portant risk factor for the development of premalignant
cervical intraepithelial neoplasia (CIN1-3) and cervical
cancer [6].
Since 2006, a quadrivalent vaccine that induces protection
against HPV types 6, 11, 16 and 18 (Gardasil®), and in 2007
a bivalent vaccine against HPV type 16 and 18 (Cervarix®)
are available. Both have shown an efficacy of >90% in pre-
venting CIN2/3 [7,8].
In the Netherlands, the bivalent HPV vaccine (Cervarix®)
targeting 12-year-old girls became part of the NationalLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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http://www.biomedcentral.com/1471-2458/14/288Immunisation Program in 2010. In 2009, girls aged 13 to
16 years were offered this vaccine during a “catch-up” vac-
cination program where the uptake amounted to 52% [9].
HPV vaccination uptake depends on diverse factors. In the
United Kingdom, schoolgirls from ethnic minorities had a
lower vaccine uptake and in the United States, girls with
lower socio-economic status were less likely to take up the
full 3 doses of the vaccine [10,11]. In the Netherlands, a
cervical cancer screening program runs since 1976. Cur-
rently, the program provides organized cervical cytological
screening every five years for women aged 30–60 years. In
2005, there was a 65% attendance to the cervical screening
program [12]. However, when including opportunistic
screening figures, the overall coverage for cervical screen-
ing amounted to 77% nationwide [13]. It has been shown
that in the Netherlands, socio-economically disadvantaged
women and women of non–Dutch nationality attend the
national cervical screening program less frequently [14].
More than half of the cervical cancers are diagnosed in
women who do not attend the Dutch screening program
[15,16]. Reducing the occurrence of cervical cancer might
thus be hampered if girls who tend to decline HPV vaccin-
ation now are also screened less often in the future. This
might lead to inequity, i.e. unequal fairness or justice in
the way people are treated.
Prior to introduction of vaccination, some studies have
reported on girls’ intention to be vaccinated [17-19].
However, little is known about the characteristics of girls
in relation to actual HPV vaccination uptake [20,21].
This study aims to explore differences between vacci-
nated and unvaccinated girls with regard to characteris-
tics such as education, ethnicity, (sexual) risk behaviour
and knowledge of HPV. Understanding the features of
these two groups could provide insight in future vaccine
and screening targeting efforts.
Methods
Study population and study design
A nationwide self-reported cross-sectional study of 16-
17-year-old girls was performed in the Netherlands in
December 2010. A random sample of 19,939 girls born
in 1993, invited for the HPV catch-up vaccination cam-
paign in 2009 (9992 vaccinated and 9947 unvaccinated),
was selected from the national vaccination database
(Praeventis) held at the National Institute for Public
Health and the Environment (RIVM) [22].
A semi-structured questionnaire was developed, pre-
tested and applied to the study population via online re-
search survey software (EFS Survey version 8.1, Unipark
(Questback)). The questionnaire contained pre-coded
questions on the following topics: Socio-demographic: edu-
cation level (girl and parents), ethnicity (Dutch, Turkish,
Moroccans, Surinamese, Antilleans, Arubans and other),
religion, alcohol and smoking behaviour. Sexual behaviour:e.g. ever have had sexual contact (vaginal or anal), age of
sexual debut, use of contraceptives (especially condom use),
number of sexual partners, type of current partner (steady/
casual) and history of STI. HPV knowledge and HPV vac-
cination: e.g. modes of transmission, protection level of
HPV vaccination, risk of infection and participation in the
cervical cancer screening program. Each girl selected for
the study received an invitation by post with an information
letter for the girl and one for her parents/caretakers, and a
link and a unique code to access the online questionnaire.
The questionnaire took approximately ten minutes to fill
out and the information was processed anonymously.
This research was performed according to the principles
contained in the Declaration of Helsinki [23]. The Dutch
Central Committee on Research Involving Human Subjects
(Centrale Commissie Mensgebonden Onderzoek (CCMO))
decided that the nature of the study did not require
mandatory approval of a competent medical-ethical review
committee, in agreement with the Dutch Medical Research
involving Human Subjects Act. The CCMO allowed to re-
ceive consent from the participating girls through the on-
line system (no written consent from the girls or their
parents was required).
Statistical analysis
Differences in socio-demographic characteristics, sexual
behaviour and knowledge of HPV between vaccinated
and unvaccinated women were compared in contingency
tables using χ2 test. Socio-economic status was also
assessed using the ‘status score’ computed by the Dutch
Institute for Social Research (SCP, www.scp.nl), as a
proxy for socioeconomic status (SES). This score takes
into account the average income per household in a
given postcode area as well as the percentage of house-
holds with low income, without a paid job and with low
education level. The lower the score is, the higher the
socioeconomic status [24]. Knowledge scale composite
scores were calculated assigning a point for each correct
answer to 8 general knowledge questions (0–8) (general
knowledge score) and to 10 questions on HPV transmis-
sion knowledge (0–10) (transmission knowledge score).
Mean scores were compared for vaccinated and unvac-
cinated girls by a t-test. Significance was determined at
the 5% level (P-value ≤0.05).
Variables associated with vaccination status found to
approach significance (P-value ≤0.1) were fitted in a multi-
variable logistic regression model. The strength of the asso-
ciations was expressed as crude odds ratios (OR) in univari-
able analysis and as adjusted OR (aOR) in multivariable
analysis, comparing vaccinated vs. unvaccinated girls. Two
models were carried out: one including the total sample of
girls and the second comprising only sexually active girls.
The final models included those factors that remained sig-
nificant (P-value ≤0.05) after backward selection and those
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Analyses were conducted using software packages from
SAS 9.2 (SAS Institute Inc. 2010, USA).
Results
Socio-demographic and sexual behaviour characteristics
A total of 2989 females (15% of invited participants) aged
16–17 (median 17) participated in this study. Among
them, 65% received at least 1 HPV vaccination and 35%
received none. The distribution of most characteristics
was similar between vaccinated and unvaccinated girls
(Tables 1 and 2). However, vaccinated girls were more
likely to live in low urbanised areas and less likely had a
religious background. Amongst those who professed a re-
ligion, vaccinated girls were more often Catholic while un-
vaccinated girls were more often Protestant Christian. The
vaccination status between the different non-Dutch ethnic
subgroups was similar (P = 0.833), they were therefore
grouped together into a “non-Dutch” ethnic group for
analysis. Ethnicity was not associated with vaccination sta-
tus (Table 1). Drinking alcohol was reported more by vac-
cinated girls as was the use of contraceptives (Table 1). A
slightly higher percentage of vaccinated girls were sexually
active but amongst them a lower mean total number of
sexual partners in their lifetime was identified. Except for
the higher percentage of female partners in the unvaccin-
ated girls, there were no other differences in sexual behav-
iour (Table 2).
Sexual behaviour and views associated with HPV
vaccination
The majority of both vaccinated and unvaccinated girls
(97.3% vs. 98.2%) thought that HPV vaccination had not
changed their sexual behaviour, 0.8% of the girls an-
swered that use of condoms would not be needed to
protect against STIs after HPV vaccination. However,
17% of the vaccinated and 26% of the unvaccinated re-
plied that other girls would be inclined to use less con-
doms after vaccination. In addition, a higher proportion
of vaccinated girls thought HPV could not be transmit-
ted when using condoms.
General knowledge of HPV and HPV vaccination
Vaccinated girls were less aware that HPV vaccination
does not protect against all HPV types, but were more
aware that HPV vaccination does not protect against all
STIs (Table 3). In general, few girls knew that HPV may
cause genital warts (20%) and that most HPV infections
clear on their own (5%). Approximately three quarters
(73%) were aware that unprotected sex entails a higher
risk of acquiring an HPV infection. More than 80%
recognised that an HPV infection is a risk for cervical
cancer and about 68% of the girls knew that an HPV in-
fection does not always lead to cervical cancer. Alsomore than 80% knew that cervical cancer does not al-
ways lead to death. Depending on the question, a vari-
able number of girls (9% to 63%) answered ‘don’t know’.
The general knowledge score (one point for every right
answer) was similar between vaccinated and unvaccin-
ated girls.
Cervical screening
Vaccinated girls reported more often that their mother
participated in the cervical cancer screening program,
and that it would still be necessary to participate in such
a program after being vaccinated. However, they were
less aware of the existence of this program (Table 3).
Knowledge on HPV infectiousness
Most girls were familiar with the association between
unsafe vaginal sex and transmission of HPV. This know-
ledge was lower for other forms of sex, such as unsafe
anal or oral sex. A low proportion knew that HPV could
be transmitted via skin-to-skin contact or by stroking
their partner’s genitals (Table 4). The HPV transmission
knowledge score also showed no difference in univari-
able analysis.
Multivariable analysis of predictors for vaccine receipt
Variables whose association with vaccination status appro-
ached significance (P-value ≤0.1) were fitted in a multivari-
able logistic regression model (Table 5). The factors that
remained independently associated with being vaccinated
were living in low urbanised areas, consuming alcohol, not
being sexually active, using contraceptive methods and not
being aware of the cervical cancer screening program. Add-
itionally, girls ascribing to no religion and those who pro-
fessed a Catholic faith were more likely to be vaccinated
than those that were either Protestant or who belonged to
another religion. Vaccinated girls were also more likely to
report that their mothers participated in the cervical cancer
screening program or not knowing their mother’s participa-
tion status in this screening program.
Furthermore, considering perceptions of HPV, vacci-
nated girls thought more often that HPV vaccination pro-
tects against all HPV types and were less likely to think
that girls would use condoms less frequently once vacci-
nated. Interestingly, more unvaccinated girls did not know
that condoms were still needed after vaccination.
Discussion
This population-based study is one of the first that exam-
ined actual determinants for individual vaccine uptake
instead of willingness to be vaccinated. Vaccinated and un-
vaccinated girls were comparable with regard to educa-
tion, education of parents, ethnicity, most sexual risk
behaviour and had similar scores on knowledge of HPV
infection and HPV transmission. They differed with
Table 1 Socio-demographic characteristics amongst all girls participating in our study (n = 2989), the Netherlands 2010
Category Total Vaccinated Unvaccinated OR (95% CI) for
being vaccinated
P-value
N (%) n (%) n (%)
2989 (100) 1938 (65) 1051 (35)
Age ref
Median (range) 17 (16–17) 17 (16–17) 17 (16–17) 0.9 (0.6–1.2) 0.45
Ethnicity (n=2988)
Dutch 2849 (95) 1852 (96) 997 (95) ref
Non–Dutch 139 (5) 86 (4) 53 (5) 0.9 (0.6–1.2) 0.45
Degree of urbanisation (n=2971)
Low (1–1000 inhabitants) 1514 (51) 1019 (53) 495 (47) ref
High (>1000 inhabitants) 1457 (49) 908 (47) 549 (53) 0.8 (0.7–0.9) 0.004
Socio economic statusa (n=2962)
Mean (95% CI) −0.01(−0.03–0.03) −0.02 (−0.06–0.02) 0.02 (−0.03–0.07) 0.9 (0.9–1.0) 0.20
Religion (n=2898)
No religion 1532 (53) 1050 (56) 482 (48) ref
Catholics 708 (24) 511 (27) 197 (19) 1.2 (1.0–1.5)
Protestant Christian 642 (22) 317 (17) 325 (32) 0.4 (0.4–0.5)
Other 16 (1) 6 (0.3) 10 (1) 0.3 (0.1–0.7) <0.001
Educationb
Low 221 (7) 148 (8) 73 (7) ref
Middle 992 (33) 631 (33) 361 (34) 0.9 (0.6–1.2)
High 1776 (59) 1159 (60) 617 (59) 0.9 (0.7–1.2) 0.54
Education of parentsb (n=2787)
Low 49 (2) 28 (2) 21(2) ref
Middle 1162 (42) 749 (41) 413 (42) 1.4 (0.8–2.4)
High 1576 (57) 1031 (57) 545 (56) 1.4 (0.8–2.5) 0.45
Alcohol use (n=2983)
No 723 (24) 425 (22) 298 (28) ref
Yes 2260 (76) 1509 (78) 751 (72) 1.4 (1.2–1.7) <0.001
Smoking (n=2984)
No 2280 (76) 1492 (77) 788 (75) ref
Current smoker 476 (16) 299 (15) 177 (17) 0.9 (0.7–1.2)
Former smoker 228 (8) 144 (7) 84 (8) 0.9 (0.7–1.1) 0.47
Contraception (n=2910)
No 902 (31) 533 (28) 369 (37) ref
Yes 2008 (69) 1371 (72) 637 (63) 1.5 (1.3–1.8) <0.001
Type of contraception (n=2003)
Pill 1253 (63) 848 (62) 405 (64) ref
Condom 160 (8) 100 (7) 60 (9) 0.8 (0.6–1.1)
Pill and condom 544 (27) 385 (28) 159 (25) 1.2 (0.9–1.4)
Other 46 (2) 34 (2) 12 (2) 1.4 (0.7–2.7) 0.18
Ever had sex (n=2898)
No 1303 (45) 826 (44) 477 (48) ref
Yes 1595 (55) 1070 (56) 525 (52) 1.2 (1.0–1.4) 0.04
aCombination of the average income per household with percentage of households with low income, without a paid job and with low average education resulting
in a score ranging [−4;+4]. Note that the lower the score is, the higher the socioeconomic status is [24].
bLow = no education or primary education; Middle = junior technical school, lower general or intermediate vocational secondary education; High = higher
vocational or higher general secondary education, pre-university/university education.
Missing values are deducted from the total number of girls.
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Table 2 Sexual risk factors amongst sexually active girls participating in our study (n = 1595), the Netherlands 2010
Category Total Vaccinated Unvaccinated OR (95% CI) for
being vaccinated
P-value
N (%) n (%) n (%)
1595 (100) 1070 (67) 525 (33)
Steady partner (n=1588)
No 510 (32) 336 (32) 174 (33) ref
Yes 1078 (68) 729 (68) 349 (67) 1.1 (0.9–1.4) 0.49
Number of casual partners (n=1589)
0 806 (51) 553 (52) 253 (48) ref
1 602 (38) 402 (38) 200 (38) 0.9 (0.7–1.2)
2 125 (8) 75 (7) 50 (10) 0.7 (0.5–1.0)
>2 56 (4) 35 (3) 21 (4) 0.8 (0.4–1.4) 0.24
Condom use steady partner (n=1078)
Always 193 (18) 126 (17) 67 (19) ref
Not always 885 (82) 603 (83) 282 (81) 1.1 (0.8–1.6) 0.44
Condom use casual partner (n=778)
Always 219 (28) 144 (28) 75 (28) ref
Not always 559 (72) 364 (72) 195 (72) 1.0 (0.7–1.3) 0.87
STI (n=780)
No 641 (82) 423 (83) 218 (80) ref
Yes 139 (18) 86 (17) 53 (20) 0.8 (0.6–1.2) 0.36
Sex of partner (n=1589)
Male 1560 (98) 1051 (99) 509 (97) ref
Female 29 (2) 15 (1) 14 (3) 0.5 (0.2–1.1) 0.08
Age of sexual debut (n=1579)
Mean (95% CI) 15.5 (15.4–15.6) 15.5 (15.5–15.6) 15.4 (15.3–15.5) 1.2 (1.0–1.3) 0.74
Total number of lifetime sexual partners (n=1584)
Mean (95% CI) 2.0 (1.9–2.1) 1.9 (1.8–2.0) 2.2 (2.0–2.4) 0.9 (0.9–1.0) <0.001
Missing values are deducted from the total number of sexually active girls.
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gion, contraceptive use, number of lifetime sexual partners
and importantly, their opinions on the use of condoms
after HPV vaccination and the protection of vaccination
against all HPV types.
Studies in the Netherlands have shown that women
who are non-Dutch nationals and have a lower socio-
economic status are less likely to participate in the cer-
vical cancer screening program [14,15]. These risk fac-
tors for non-attendance were not observed in this study
for girls who chose not to be vaccinated. We found no
relationship between uptake and ethnicity, nor education
of the girl or their parents or SES score (both indicators
of socio-economic status), which could suggest that the
two programs might strengthen each other Another
Dutch study also concluded that vaccination and screen-
ing (assessed by reported screening behaviour of the
mother) complement each other to a large extent [25].
Religion has influenced vaccination decision-making
process since the beginning of vaccination efforts [26].Anti-vaccination proponents were most common in coun-
tries with a high proportion of Protestants [27]. In our
study, identifying as a Protestant Christian was related to a
lower vaccination uptake, as opposed to identifying as a
Catholic or not following a religion. In addition to specific
religious groups among the Protestant Christians (such as
Orthodox reformed), the reluctance towards HPV vaccin-
ation might be extended amongst a broader group of Prot-
estant Christians because of the link with a sexually
transmitted infection. Participation in screening programs
has not been found to be lower in Dutch regions with
higher proportion of religious groups [25], highlighting
again the possible complementarity between screening
and vaccination.
Contradicting results regarding the influence of HPV
knowledge and perceptions on vaccination uptake have
been reported [28]. Consistent with a Dutch study on ac-
ceptance of HPV vaccination [29], we obtained no differ-
ences on vaccination uptake with regard to the general
HPV knowledge score, nor on the HPV transmission
Table 3 HPV general knowledge amongst all girls participating in our study (n = 2989), the Netherlands 2010
Category Total Vaccinated Unvaccinated OR (95% CI) for
being vaccinated
P-value
N (%) n (%) n (%)
2989 (100) 1938 (65) 1051 (35)
HPV vaccination protects against all HPV types (n=2910)
No 1811 (62) 1110 (58) 701 (70) ref
Yes 373 (13) 291 (15) 82 (8) 2.2 (1.7–2.9)
Don’t know 726 (25) 505 (27) 221 (22) 1.4 (1.2–1.7) <0.001
HPV vaccination protects against all STIs (n=2909)
No 2567 (88) 1702 (89) 865 (86) ref
Yes 52 (2) 33 (2) 19 (2) 0.9 (0.5–1.6)
Don’t know 290 (10) 170 (9) 120 (12) 0.7 (0.6–0.9) 0.03
An HPV infection always leads to cervical cancer (n=2930)
No 1984 (68) 1294 (68) 690 (68) ref
Yes 121 (4) 80 (4) 41 (4) 1.0 (0.7–1.5)
Don’t know 825 (28) 541 (28) 284 (28) 1.0 (0.9–1.2) 0.97
Cervical cancer is always fatal (n=2930)
No 2414 (82) 1579 (82) 835 (82) ref
Yes 141 (5) 98 (5) 43 (4) 1.2 (0.8–1.8)
Don’t know 375 (13) 238 (12) 137 (14) 0.9 (0.7–1.2) 0.43
If you have unprotected sex, you are at high risk of an HPV infection (n=2930)
No 311 (11) 193 (10) 118 (12) ref
Yes 2143 (73) 1411 (74) 732 (72) 1.2 (0.9–1.5)
Don’t know 476 (16) 311 (16) 165 (16) 1.2 (0.9–1.6) 0.42
An HPV infection is a risk for cervical cancer (n=2930)
No 215 (7) 144 (8) 71 (7) ref
Yes 2370 (81) 1555 (81) 815 (80) 0.9 (0.7–1.3)
Don’t know 345 (12) 216 (11) 129 (13) 0.8 (0.6–1.2) 0.48
An HPV infection can cause genital warts (n=2929)
No 537 (18) 354 (18) 183 (18) ref
Yes 582 (20) 389 (20) 193 (19) 1.0 (0.8–1.3)
Don’t know 1810 (62) 1172 (61) 638 (63) 1.0 (0.8–1.2) 0.63
An HPV infection usually disappears on its own (n=2930)
No 1969 (67) 1301 (68) 668 (66) ref
Yes 136 (5) 80 (4) 56 (6) 0.7 (0.5–1.0)
Don’t know 825 (28) 534 (28) 291 (29) 0.9 (0.8–1.1) 0.21
Awareness of CC screening program (n=2910)
No 1421 (49) 984(52) 437 (43) ref
Yes 1489 (51) 921 (48) 568 (57) 0.7 (0.6–0.8) <0.001
Participation of mother in CC screening program (n=2910)
No 670 (23) 410 (22) 260 (26) ref
Yes 1192 (41) 798 (42) 394 (39) 1.3 (1.1–1.6)
Don’t know 1048 (36) 697 (37) 351 (35) 1.3 (1.0–1.5) 0.03
Need to participate in the CC screening program after vaccination (n=2910)
No 174 (6) 115 (6) 59 (6) ref
Yes 2013 (69) 1346 (71) 667 (66) 1.0 (0.7–1.4)
Don’t know 723 (25) 444 (23) 279 (28) 0.8 (0.6–1.2) 0.03
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Table 3 HPV general knowledge amongst all girls participating in our study (n = 2989), the Netherlands 2010
(Continued)
Condoms are not needed anymore once vaccinated (n=2909)
No 2781 (96) 1842 (97) 939 (94) ref
Yes 22 (1) 15 (1) 7 (1) 1.1 (0.5–2.9)
Don’t know 106 (3) 48 (3) 58 (6) 0.4 (0.3–0.6) <0.001
Girls will use less condoms once vaccinated (n=2909)
No 1526 (52) 1076 (56) 450 (45) ref
Yes 574 (20) 317 (17) 257 (26) 0.5 (0.4–0.6)
Don’t know 809 (28) 512 (27) 297 (30) 0.7 (0.6–0.9) <0.001
General knowledge score
mean (95% CI) 5.52 (5.48–5.56) 5.51 (5.47–5.56) 5.53 (5.47–5.59) 0.62
CC = cervical cancer.
Missing values are deducted from the total number of girls.
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as 80% of the girls knew of the relationship between HPV
and cervical cancer, which was similar to some other stud-
ies (81% Lenselink CH et al. [29], 84% Gerend MA and
Shepherd JE [28], 85-93% Marlow LA et al. [30] program.
In general, only 50% of the young girls in our study
recognised that after an HPV vaccination it is still indi-
cated to participate in the cervical cancer screening pro-
gram (which takes place from age 30 onwards in the
Netherlands). This fact has also been reported by Bow-
yer HL et al. [31] amongst a group of 15–16 year old
girls, where only 47% was aware cervical screening is
still necessary after vaccination. We also found that vac-
cinated girls were less aware of the fact that vaccination
does not protect against all HPV types. The continued
importance of cervical screening in the Netherlands has
to be emphasised along with the benefits of HPV vaccin-
ation. The finding that vaccinated girls report more
often that their mothers participate in the cervical can-
cer screening program seems somewhat contradictory to
their lower awareness about this program. Paulussen TG
et al. [32] reported that a major part of the population
does not make a well thought decision with regard to
vaccinations in the regular National Immunization Pro-
gram). These parents regard vaccination as self-evident.
Similarly, this might be so for a part of mothers with re-
gard to participation in screening, which possibly results
in less discussion on the topic and thus less knowledge
among their daughters.
In our study, only 2-3% reported that HPV vaccination
had changed their sexual behaviour in the first year after
vaccination. However, Marlow LA et al. [33] found that
one-third of adolescent girls interviewed, thought that
HPV vaccination would make girls in general more likely
to have unsafe sex. Swedish high-school students did not
think it that they themselves would engage in more un-
safe sex after HPV vaccination but that other girls might
[34]. We found a similar opinion concerning anticipatedrisk behaviour and condom use. Nearly all girls reported
that they would not reduce condom use after HPV vac-
cination (only 1% for both groups), but 17% (vaccinated)
and 26% (unvaccinated) thought other girls would.
There were no significant differences amongst vaccinated
and unvaccinated girls for reported condom use with a cas-
ual or steady partner. However, sexually active vaccinated
girls were more aware of the risk of HPV infection when
engaging in unprotected sex. Irrespective of vaccination sta-
tus, only a quarter of the girls reported to always use con-
doms with a casual partner and 18% with a steady partner.
In line with Mather T et al. [35] inconsistent or no condom
use was reported by 50% of the girls with a casual partner.
Although most of the girls (65%) in our study reported
using other contraceptive methods, the risk of acquiring
HPV or another STI through unprotected sex seems to be
high in this population. Therefore, early HPV vaccination
of 12-year-old girls will considerably decrease the risk of
HPV infection at a later and more sexually active age.
With regard to other sexual risk factors we found that
among the vaccinated sexually active girls, a somewhat
lower mean number of lifetime sexual partners was re-
ported. However, no differences were found for other sex-
ual behavioural characteristics such as age of sexual debut
and history of STIs. These results imply that girls who de-
cided not to get vaccinated were not the ones with in-
creased (sexual) risk behaviour. Thus in contrast to
screening, where it has been found that more than half of
the cervical cancer cases were found in women who did
not attend screening, it seems that although these girls are
not benefiting from vaccination, they have no dispropor-
tional disadvantage compared to vaccinated girls.
This study has several strengths. Firstly, it was a randomly
selected, large, nationwide population-based study. Sec-
ondly, vaccination status was derived from a national vac-
cination database instead of being self-reported. Thirdly, we
obtained information on the actual vaccination uptake in-
stead of the intention to vaccinate.
Table 4 HPV transmission knowledge amongst all girls participating in our study (n = 2989), the Netherlands 2010
Category Total Vaccinated Unvaccinated OR (95% CI) for
being vaccinated
P-value
N (%) n (%) n (%)
2989 (100) 1938 (65) 1051 (35)
HPV can be transmitted via;
Holding hands (no) (n=2924)
No 2884 (99) 1882 (99) 1002 (99) ref
Yes 40 (1) 28 (1) 12 (1) 1.2 (0.6–2.5) 0.53
Deep throat kissing (no) (n=2927)
No 2622 (90) 1711 (89) 911 (90) ref
Yes 305 (10) 202 (11) 103 (10) 1.0 (0.8–1.3) 0.74
Skin to skin contact (yes) (n=2926)
No 2646 (90) 1727 (90) 919 (91) ref
Yes 280 (10) 185 (10) 95 (9) 1.0 (0.8–1.3) 0.79
Stroking partner at genitals (yes) (n=2927)
No 2000 (68) 1326 (69) 674 (66) ref
Yes 927 (32) 587 (31) 340 (34) 0.9 (0.7–1.0) 0.12
Public toilet (no) (n=2926)
No 2411 (82) 1575 (82) 836 (83) ref
Yes 515 (18) 338 (18) 177 (17) 1.0 (0.8–1.2) 0.89
Unprotected oral sex (yes) (n=2928)
No 1078 (37) 695 (36) 383 (38) ref
Yes 1850 (63) 1219 (64) 631 (62) 1.1 (0.9–1.2) 0.44
Unprotected vaginal sex (yes) (n=2929)
No 144 (5) 96 (5) 48 (5) ref
Yes 2785 (95) 1818 (95) 967 (95) 0.9 (0.7–1.3) 0.73
Unprotected anal sex (yes) (n=2928)
No 865 (30) 568 (30) 297 (29) ref
Yes 2063 (70) 1345 (70) 718 (71) 1.0 (0.8–1.2) 0.81
Sex with a condom (n=2927)
No 2533 (87) 1674 (88) 859 (85) ref
Yes 394 (12) 238 (12) 156 (15) 0.8 (0.6–1.0) 0.03
Sharing a spoon or cup (no) (n=2925)
No 2739 (94) 1777 (93) 962 (95) ref
Yes 186 (6) 134 (7) 52 (5) 1.4 (1.0–2.0) 0.05
Sneezing/coughing (no) (n=2924)
No 2753 (94) 1794 (94) 959 (95) ref
Yes 171 (6) 116 (6) 55 (5) 1.1 (0.8–1.6) 0.48
Transmission knowledge score
Mean (95% CI) 7.24 (7.19–7.28) 7.24 (7.16–7.31) 7.24 (7.18–7.29) 0.99
Missing values are deducted from the total number of girls.
Correct answer is shown in brackets.
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sponse rate (15%), online surveys/questionnaires, while ad-
vantageous, are known for their average lower response rate
compared to mail or telephone surveys [36,37]. Similar or
lower response rates were obtained in other studies directed
to parents of girls targeted for HPV catch-up vaccination(16%-24%) [38] or to participants recruited from Praeventis
(7%) [39]. The response was higher amongst vaccinated than
unvaccinated girls (19% vs. 11%) similar to other studies
[38]. In order to assess the effect of this response rate we de-
termined if the characteristics of the study population were
similar to those of girls in the general population, by
Table 5 Multivariable analysis amongst all girls participating in our study (n = 2989), the Netherlands 2010
Risk factor Univariablea Multivariableb,c P-value
OR (95% CI) aOR (95% CI)
Degree of urbanisation
Low (1–1000 inhabitants) ref ref
High (>1000 inhabitants) 0.8 (0.7–0.9) 0.8 (0.7–1.0) 0.02
Religion
No religion ref ref
Catholics 1.2 (1.0–1.5) 1.2 (0.9–1.4) 0.15
Protestant Christian 0.4 (0.4–0.5) 0.5 (0.4–0.6) <0.001
Other 0.3 (0.1–0.7) 0.3 (0.1–0.9) 0.03
Alcohol use
No ref ref
Yes 1.4 (1.2–1.7) 1.3 (1.0–1.6) 0.01
Contraception
No ref ref
Yes 1.5 (1.3–1.8) 1.5 (1.2–1.9) <0.001
Ever had sex
No ref ref
Yes 1.2 (1.0–1.4) 0.8 (0.6–1.0) 0.04
Awareness of CC screening program
No ref ref
Yes 0.7 (0.6–0.8) 0.7 (0.6–0.8) <0.001
Participation of mother to CC screening program
No ref ref
Yes 1.3 (1.1–1.6) 1.6 (1.2–2.0) <0.001
Don’t know 1.3 (1.0–1.5) 1.3 (1.0–1.6) 0.03
HPV vaccination protects against all HPV types
No ref ref
Yes 2.2 (1.7–2.9) 2.4 (1.8–3.2) <0.001
Don’t know 1.4 (1.2–1.7) 1.5 (1.2–1.8) <0.001
Girls will use less condoms once vaccinated
No ref ref
Yes 0.5 (0.4–0.6) 0.5 (0.4–0.6) <0.001
Don’t know 0.7 (0.6–0.9) 0.7 (0.5–0.8) 0.002
Condom use is not needed anymore once vaccinated
No ref ref
Yes 1.1 (0.5–2.9) 1.5 (0.5–5.6) 0.5
Don’t know 0.4 (0.3–0.6) 0.4 (0.2–0.6) <0.001
CC = cervical cancer.
a196 cases missing.
bOnly variables with a P–value less than 0.1 in the univariable analysis were entered.
cnot significant in multivariable analysis, (P > 0.05) (not presented in Table): HPV can be transmitted via a spoon, HPV can be transmitted when using condoms.
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ual debut. Girls in our study were comparable with respect
to sexual debut with another Dutch study [40] but were
slightly higher educated than the general Dutch population
(59% vs. 47%), and were more often not Dutch (4.7% vs.3.3%) [41]. Nevertheless, our sample size was adequate for
the proposed statistical analysis of association with vaccine
uptake and the possible influence of differences in ethnicity
and education were controlled for in the multivariable ana-
lysis. Finally, although we have no indications that our
Mollers et al. BMC Public Health 2014, 14:288 Page 10 of 11
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geted in the routine HPV vaccination program, we cannot
rule out that this might be somewhat different. That is, the
decision-process towards vaccine uptake may be more influ-
enced by parents/caregivers in this younger age group.
Conclusions
Routine HPV vaccination in the Netherlands has the po-
tential to reduce the inequity of prevention of cervical
cancer. In particular, vaccination uptake was not associ-
ated with factors that are known to be associated with
non-attendance in the cervical cancer screening pro-
gram, such as education and ethnicity. Furthermore,
most sexual characteristics were comparable amongst
both groups indicating that unvaccinated girls are prob-
ably not at higher risk of exposure to HPV compared to
vaccinated girls. Although in general knowledge could
be improved, the large majority of participants knew
HPV caused cervical cancer suggesting an informed vac-
cination choice was made.
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